Taxorest delivers Bosom Peptides to bronchial tissue, promoting airway epithelial cell renewal and smooth-muscle regulation. It helps maintain open, responsive airways and supports the bronchial tree's self-repair mechanisms.
Taxorest is a precision-engineered bioregulator peptide that selectively targets bronchial tissue through epigenetic signalling pathways. Developed from decades of Khavinson peptide research, each capsule contains ultra-short amino acid sequences (2-4 residues) that penetrate cell membranes to interact directly with tissue-specific DNA. By restoring natural gene expression patterns within bronchial tissue cells, Taxorest helps normalise bronchial smooth-muscle regulation and airway epithelial renewal—functions that progressively decline with age, stress, and environmental exposure. The peptide does not introduce foreign substances; instead, it reactivates the body's own molecular programmes for respiratory tissue maintenance, making it a fundamentally different approach from conventional supplementation.